Overview

Spironolactone After Liver Transplant

Status:
Completed
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
To study spironolactone to prevent calcineurin inhibitor (CNI) kidney injury.
Phase:
Phase 4
Details
Lead Sponsor:
Atrium Health
Carolinas Healthcare System
Treatments:
Spironolactone